Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
Andreas Fibig, CEO and Chairman of IFF, will retire after a decade with the company. The Board is currently evaluating successors and expects to announce a new CEO by early 2022. Fibig noted IFF's strong sales growth and successful integration of Nutrition & Biosciences, expressing pride in transforming the company into a sustainability leader. His retirement marks a significant transition, but he will assist in the handover process. IFF aims to continue driving long-term value for stakeholders while navigating the ongoing challenges of the market.
IFF (NYSE: IFF) has appointed Glenn Richter as Executive Vice President and Chief Financial Officer, effective September 27, 2021. Richter, formerly CFO at TIAA, succeeds Rustom Jilla. IFF has updated its financial guidance for 2021, projecting sales growth exceeding 8% to around $11.55 billion, with a third-quarter double-digit growth outlook. However, adjusted operating EBITDA margin is revised to approximately 21.5%, reflecting inflationary pressures on costs. The company emphasizes confidence in addressing these challenges while enhancing shareholder value.
On September 9, 2021, IFF (NYSE: IFF) will host a virtual fireside chat featuring Chairman & CEO Andreas Fibig and President of Nourish Nicolas Mirzayantz at 12 pm ET during the Barclays 2021 Global Consumer Staples Conference. Investors can access the live webcast and presentation slides on the company's website, with a replay available afterward. IFF is recognized for its innovative contributions across industries, including food, beverage, scent, health, and biosciences, and aims to create sustainable solutions that benefit both people and the planet.
IFF has entered into a $1.3 billion agreement to sell its Microbial Control business unit to LANXESS. The proceeds will primarily be used to reduce outstanding debt, enhancing IFF’s financial profile. The Microbial Control unit generated approximately $440 million in annual revenue and $85 million in EBITDA in 2021, focusing on preservation and hygiene solutions across various industries. IFF aims for a seamless transition, expecting the deal to close in the second quarter of 2022, subject to regulatory approvals.
International Flavors & Fragrances reported Q2 2021 results with revenue of $3.1 billion, representing a 158% increase year-over-year, primarily due to the merger with Nutrition & Biosciences. Adjusted operating EBITDA reached $679 million, up 184%, while EPS was $0.11 or $1.50 excluding amortization. The firm anticipates 7% growth for the full year and has increased its quarterly dividend by 3%, marking its twelfth consecutive year of hikes. Despite strong cash flow generation, margins faced pressures from rising raw material costs.
IFF (NYSE: IFF) has appointed Nicolas Mirzayantz as the new President of its Nourish division, effective September 1, 2021. He succeeds Kathy Fortmann, who is leaving to explore other opportunities. Mirzayantz brings extensive experience from his previous role as President of the Scent division, where he achieved a 5% compound annual growth rate. Christophe de Villeplee will take over Mirzayantz's former role as President of Scent. The leadership transition aims to leverage IFF's strong product portfolio and innovation to drive growth in the global food and beverage sector.
IFF (NYSE:IFF) will release its second quarter 2021 earnings results on August 5, 2021, after market close. A live webcast will take place on August 6, 2021, at 10:00 a.m. ET, to discuss the results and outlook. Investors can access both the live and recorded versions of the webcast on the Company's website.
As a leader in food, beverage, scent, health, and biosciences, IFF focuses on combining science and creativity to deliver innovative solutions that meet global demand.
On May 20, 2021, IFF (NYSE: IFF) launched its Science of Wellness program in response to consumer demand for holistic wellbeing solutions. This initiative leverages over forty years of fragrance research and advanced AI technology to create scents that offer emotional and cognitive benefits. The wellness market is expected to grow annually by 5 to 10% by 2025. An IFF study indicated that 87% of consumers prefer fragrances with wellness benefits. The program aims to innovate in fragrance design, utilizing extensive data to inform product development.
International Flavors & Fragrances reported Q1 2021 results with net sales of $2.47 billion, an 83% increase year-over-year, primarily due to its merger with Nutrition & Biosciences. Adjusted EBITDA rose 88% to $569 million, while reported EPS was $(0.21). The company plans to divest its fruit preparation business, expected to close in Q3 2021, contributing about $70 million in sales.
The updated 2021 sales guidance is approximately $11.25 billion, with an adjusted operating EBITDA margin of ~23%.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
